Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Cancer × capivasertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Leukemia 2 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Melanoma 1 Lymphoma 1 Lung Neoplasms 1 Endometrial Neoplasms 1 Disease Progression 1 Chondrosarcoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 CCCA Assessed by Ki67 Drop Below <2.7% From Baseline 1 Advanced Gastric Cancer 1 Advanced Cancer 1 Advanced Breast Cancer 1 Adenocarcinoma 1

Interventions

Surveys and Questionnaires 7 Bevacizumab 5 temsirolimus 4 Standard of Care 4 Sirolimus 4 Interviews as Topic 4 Vorinostat 2 Paclitaxel 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Erlotinib Hydrochloride 2 Cetuximab 2 zaleplon 1 vistusertib 1 tilsotolimod 1 pazopanib 1 olaparib 1 liposomal doxorubicin 1 capivasertib 1 apatinib 1 Videotape Recording 1 Vemurafenib 1 Valproic Acid 1 Trastuzumab 1 Topotecan 1 Temozolomide 1 Sunitinib 1 Sorafenib 1 Rehabilitation 1 Referral and Consultation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02338622 2024-09-26

ComPAKT

Royal Marsden NHS Foundation Trust

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡